HUMA
Price
$1.50
Change
-$0.05 (-3.23%)
Updated
Sep 2, 04:38 PM (EDT)
Capitalization
245.48M
66 days until earnings call
LTRN
Price
$4.03
Change
-$0.05 (-1.23%)
Updated
Sep 2, 04:45 PM (EDT)
Capitalization
44.06M
64 days until earnings call
Interact to see
Advertisement

HUMA vs LTRN

Header iconHUMA vs LTRN Comparison
Open Charts HUMA vs LTRNBanner chart's image
Humacyte
Price$1.50
Change-$0.05 (-3.23%)
Volume$400
Capitalization245.48M
Lantern Pharma
Price$4.03
Change-$0.05 (-1.23%)
Volume$350
Capitalization44.06M
HUMA vs LTRN Comparison Chart in %
Loading...
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HUMA vs. LTRN commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HUMA is a Buy and LTRN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (HUMA: $1.55 vs. LTRN: $4.08)
Brand notoriety: HUMA and LTRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HUMA: 52% vs. LTRN: 23%
Market capitalization -- HUMA: $245.48M vs. LTRN: $44.06M
HUMA [@Biotechnology] is valued at $245.48M. LTRN’s [@Biotechnology] market capitalization is $44.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HUMA’s FA Score shows that 0 FA rating(s) are green whileLTRN’s FA Score has 0 green FA rating(s).

  • HUMA’s FA Score: 0 green, 5 red.
  • LTRN’s FA Score: 0 green, 5 red.
According to our system of comparison, LTRN is a better buy in the long-term than HUMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HUMA’s TA Score shows that 4 TA indicator(s) are bullish while LTRN’s TA Score has 4 bullish TA indicator(s).

  • HUMA’s TA Score: 4 bullish, 6 bearish.
  • LTRN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LTRN is a better buy in the short-term than HUMA.

Price Growth

HUMA (@Biotechnology) experienced а -1.90% price change this week, while LTRN (@Biotechnology) price change was -9.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.61%. For the same industry, the average monthly price growth was +22.15%, and the average quarterly price growth was +32.80%.

Reported Earning Dates

HUMA is expected to report earnings on Nov 07, 2025.

LTRN is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HUMA($245M) has a higher market cap than LTRN($44.1M). LTRN YTD gains are higher at: 27.900 vs. HUMA (-69.307). LTRN has higher annual earnings (EBITDA): -20.48M vs. HUMA (-40.86M). HUMA has more cash in the bank: 38M vs. LTRN (15.9M). LTRN has less debt than HUMA: LTRN (145K) vs HUMA (15.1M). HUMA has higher revenues than LTRN: HUMA (818K) vs LTRN (0).
HUMALTRNHUMA / LTRN
Capitalization245M44.1M556%
EBITDA-40.86M-20.48M199%
Gain YTD-69.30727.900-248%
P/E RatioN/AN/A-
Revenue818K0-
Total Cash38M15.9M239%
Total Debt15.1M145K10,414%
TECHNICAL ANALYSIS
Technical Analysis
HUMALTRN
RSI
ODDS (%)
Bullish Trend 5 days ago
84%
Bearish Trend 5 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
87%
Momentum
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 5 days ago
85%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 7 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
87%
Bearish Trend 5 days ago
81%
Aroon
ODDS (%)
Bearish Trend 5 days ago
78%
Bullish Trend 5 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
HUMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCCEF0.03N/A
+10.21%
BacTech Environmental Corporation
PBIGF0.190.02
+8.82%
Paradigm Biopharmaceuticals Ltd.
SPPJY1.70N/A
N/A
Sappi Ltd.
SZHFF21.50N/A
N/A
Sojitz Corp.
DKILY12.48-0.24
-1.89%
Daikin Industries Ltd.

HUMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HUMA has been loosely correlated with ACRV. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HUMA jumps, then ACRV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HUMA
1D Price
Change %
HUMA100%
-1.90%
ACRV - HUMA
38%
Loosely correlated
+0.75%
IMVT - HUMA
37%
Loosely correlated
-0.88%
LTRN - HUMA
36%
Loosely correlated
+0.49%
CYTK - HUMA
36%
Loosely correlated
-5.41%
DMAC - HUMA
35%
Loosely correlated
-2.73%
More

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with DNA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then DNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
+0.49%
DNA - LTRN
35%
Loosely correlated
+4.11%
HUMA - LTRN
35%
Loosely correlated
-1.90%
MNMD - LTRN
34%
Loosely correlated
-9.20%
BDTX - LTRN
31%
Poorly correlated
-3.51%
ATAI - LTRN
31%
Poorly correlated
-1.51%
More